---
title: "SHAYDULLINA LEYSAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/011f829d-aeac-535b-944a-e28c7fd14f3b
json: https://whiteintel.dev/api/public/dossier/011f829d-aeac-535b-944a-e28c7fd14f3b
identifier: sec:0001677493
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SHAYDULLINA LEYSAN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001677493`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/011f829d-aeac-535b-944a-e28c7fd14f3b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/011f829d-aeac-535b-944a-e28c7fd14f3b  

## Ownership & control

### Holdings / subsidiaries

- **Cartesian Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/595d5f58-f9b0-50ec-bf90-fb0e83f33dcd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SHAYDULLINA LEYSAN**. Human view: https://whiteintel.dev/entity/011f829d-aeac-535b-944a-e28c7fd14f3b · Structured JSON: https://whiteintel.dev/api/public/dossier/011f829d-aeac-535b-944a-e28c7fd14f3b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._